Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.JP |
First Approval Date18 May 1991 |
100 Clinical Results associated with Kenei Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Kenei Pharmaceutical Co., Ltd.
31 May 2022·Igaku to Yakugaku
Investigation of effectiveness of ethanoI-containing disinfectants against various viruses (SARS-CoV-2. influenza a virus of norovirus)
Author: Takahiro, Minami ; Yasuhito, Taga ; Yoshihiro, Okamura
100 Deals associated with Kenei Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Kenei Pharmaceutical Co., Ltd.